Document Detail


Update on cytogenetic and molecular changes in myelodysplastic syndromes (MDS).
MedLine Citation:
PMID:  21877899     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and a high propensity to transform to acute myeloid leukemia (AML). In the pathogenesis of the disease, both gene mutations and cytogenetic changes play an important role. The latter have been integrated into prognostic scoring systems including the IPSS (International Prognostic Scoring System) and WPSS (WHO classification-based Prognostic Scoring System). In these systems and in multivariate analyses comparing clinical and genetic data, complex karyotypes are associated with a particularly poor prognosis. Del(5q) plays a distinct role by classifying the only genetically defined WHO subtype. Also, due to advancement in technology such as whole genome sequencing, the number of known mutations occurring in MDS is steadily increasing. Important recent discoveries include mutations in EZH2, DNMT3A, ASXL1, and IDH1/2. Like TET2, the most commonly mutated gene in MDS, all are involved in epigenetic regulation. Mutations like ASXL1, RUNX1, EZH2, ETV6/TEL, and TP53 have an adverse impact on patient overall survival. Early evidence suggests that some mutations might influence treatment response, necessitating reassessment of the prognostic effect of genetic alterations in the light of every new treatment. This review discusses clinical and biological effects of the most common cytogenetic and molecular aberrations in MDS patients.
Authors:
Brigitte Schlegelberger; Gudrun Göhring; Felicitas Thol; Michael Heuser
Related Documents :
22236909 - Association study of c1qa polymorphisms with systemic lupus erythematosus in han popula...
21892769 - Snp array-based whole genome homozygosity mapping as the first step to a molecular diag...
8932709 - The defective phosphoribosyl diphosphate synthase in a temperature-sensitive prs-2 muta...
22027159 - 'lethal' combination of mycobacterium tuberculosis beijing genotype and human cd209-336...
19508229 - Functional roles of ef-hands in human potassium channel-interacting protein 2.2.
21674859 - Frequency and prognostic impact of flt3/itd mutation in patients with acute myeloid leu...
22236909 - Association study of c1qa polymorphisms with systemic lupus erythematosus in han popula...
17575499 - Update on psychiatric genetics.
17639299 - A comparison of simple sequence repeat and single nucleotide polymorphism marker techno...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-30
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  -     ISSN:  1029-2403     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  NMR spectroscopy for discovery and quantitation of biomarkers of disease in human bile.
Next Document:  An overview of systematic reviews of adaptive seating interventions for children with cerebral palsy...